DecisionPoint Financial’s Quest Diagnostics DGX Stock Holding History

DecisionPoint Financial’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.94K	Hold	15	–	–	﹤0.01%	257
2025 Q4	$2.6K	Hold	15	–	–	﹤0.01%	308
2025 Q3	$2.73K	Hold	15	–	–	﹤0.01%	216
2025 Q2	$2.69K	Buy	+15	New	+$2.6K	﹤0.01%	215

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

DecisionPoint Financial's DGX Position: Q1 2026 in Review

DecisionPoint Financial held its Quest Diagnostics (DGX) position steady in Q1 2026 at 15 shares worth $2.94K. The position accounts for ﹤0.01% of the portfolio, ranked #257.

DecisionPoint Financial first reported a position in DGX in Q2 2025 and has held it in 4 quarters since. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

DecisionPoint Financial held 15 shares of Quest Diagnostics worth $2.94K as of Q1 2026.
DecisionPoint Financial left its Quest Diagnostics share count unchanged in Q1 2026.
Quest Diagnostics made up ﹤0.01% of DecisionPoint Financial's portfolio in Q1 2026, its #257 holding.
DecisionPoint Financial first reported a position in Quest Diagnostics in Q2 2025 and has held it in 4 quarters since.
1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on DecisionPoint Financial's 13F filing for Q1 2026, filed 6 May 2026.